发明名称 CYCLIC INHIBITORS OF PROTEIN-TYROSINE KINASES
摘要 FIELD: organic chemistry, biochemistry, medicine, pharmacy. ^ SUBSTANCE: invention relates to N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazole carboxamide of the formula: and to its pharmaceutically acceptable salts. Also, invention describes a pharmaceutical composition inhibiting activity of protein-tyrosine kinases and comprising the indicated compound, a method for treatment of disorders associated with protein-tyrosine kinases, such as an immune disorder, and oncology disease, and a method for cancer treatment. ^ EFFECT: valuable biochemical and medicinal properties of compounds and composition. ^ 5 cl, 2 tbl, 581 ex
申请公布号 RU2260592(C2) 申请公布日期 2005.09.20
申请号 RU20010130452 申请日期 2000.04.12
申请人 发明人 DAS DZHAGABANDKHU;PADMANABKHA RAMESH;CHEN PING;NORRIS DEREK DZH.;DOVEJKO ARTUR M. P.;BEHRRISH DZHOEHL S.;VITJAK DZHON
分类号 C07D277/20;A61K31/426;A61K31/427;A61K31/437;A61K31/438;A61K31/454;A61K31/4709;A61K31/4725;A61K31/496;A61K31/506;A61K31/5377;A61K45/00;A61P1/00;A61P5/14;A61P9/10;A61P11/00;A61P11/02;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P21/00;A61P25/00;A61P27/02;A61P29/00;A61P35/00;A61P37/00;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07C237/40;C07D213/81;C07D213/82;C07D231/38;C07D233/90;C07D239/42;C07D263/48;C07D277/30;C07D277/40;C07D277/42;C07D277/44;C07D277/46;C07D277/56;C07D277/62;C07D409/12;C07D417/06;C07D417/12;C07D417/14;C07D471/04;C07D491/20 主分类号 C07D277/20
代理机构 代理人
主权项
地址